Allergan Aesthetics' Carrie Strom on the 'aesthetics generation' and new frontiers for injectables

Allergan Aesthetics' Carrie Strom on the 'aesthetics generation' and new frontiers for injectables

Botox has dominated the neurotoxin market since its FDA approval for cosmetic use in 2002. However, its iconic status would not be possible without the backing of global company Allergan Aesthetics. In addition to Botox, Allergan Aesthetics itself a subsidiary of pharmaceutical company AbbVie, which houses aesthetics brands including Juvéderm, SkinVive, Kybella and Coolsculpting, among others. In its full-year 2023 earnings released in February, AbbVie reported that the global net revenue of its aesthetics portfolio was about $5.3 billion, with global Botox Cosmetic's net revenue reaching $2.7 billion and global Juvéderm's net revenue equalling $1.4 billion. Leading this portfolio of aesthetics products, and guiding the future of the aesthetics industry, is Carrie Strom, svp of AbbVie and Global Allergan Aesthetics president. Strom has kept busy over the last year. In May 2023, Allergan received FDA approval for Skinvive by Juvéderm, and in early Oct. 2023, it became available for patients to receive as a treatment. Skinvive has been available in Europe since 2017 and marketed under the name “Volite.” Plus, the company has driven countless marketing moments, including the first-ever Juvéderm Day in Aug. 2023 and the fifth-annual National Botox Day in Nov. 2023. In addition, Strom has busied herself by shoring up Botox’s status, as competitors, including Jeuveau and long-lasting neurotoxin Daxxify, nip at its heels. In conversation on the Glossy Beauty podcast, Strom discussed how younger consumers are changing the aesthetics market and how Skinvive can serve as an entry point for new patients, among other topics.

Jaksot(381)

Target and Ultra break up, foam sunscreen is recalled —  plus, what makes a successful pop-up?

Target and Ultra break up, foam sunscreen is recalled —  plus, what makes a successful pop-up?

Host Lexy Lebsack is joined by reporter Melissa Daniels from Glossy’s sister publication Modern Retail and co-host of the Modern Retail Podcast, to walk through this week’s biggest beauty news stories...

21 Elo 20251h 9min

What's new in beauty brick-and-mortar, why E.l.f. is getting backlash — Dr. Thomas Sterry on plastic surgery trends

What's new in beauty brick-and-mortar, why E.l.f. is getting backlash — Dr. Thomas Sterry on plastic surgery trends

co-hosts Lexy Lebsack and Emily Jensen discuss industry news of the week, including changes to beauty brick-and-mortar retail, from Nordstrom's NYC flagship's approach to Mecca's new 40,000-square-foo...

14 Elo 202547min

An insider’s guide to K-beauty’s US renaissance, plus industry news

An insider’s guide to K-beauty’s US renaissance, plus industry news

On this week’s episode of the Glossy Beauty Podcast, co-host Lexy Lebsack interviews co-host Sara Spruch-Feiner about her recent reporting on the topic, diving into what’s fueling K-beauty’s renewed p...

7 Elo 202544min

Rare Beauty's fragrance, C-suite hires, L'Oréal earnings — and K-beauty brand Krave Beauty’s Liah Yoo

Rare Beauty's fragrance, C-suite hires, L'Oréal earnings — and K-beauty brand Krave Beauty’s Liah Yoo

Krave Beauty isn’t your average K-Beauty brand. “[Our mission] resonates with a lot of people who are really tired of the beauty industry's narrative of ‘more is more,’” CEO and co-founder Liah Yoo t...

31 Heinä 202555min

TSG Group's Phlur acquisition, Shiseido's layoffs — and everything you should know about sunscreen in the US

TSG Group's Phlur acquisition, Shiseido's layoffs — and everything you should know about sunscreen in the US

In this episode of the Glossy Beauty Podcast, board-certified dermatologist and Mohs surgeon Dr. Jane Yoo, and the Melanoma Research Foundation's director of advocacy, Kim Wezik, MPH, chat with Glossy...

24 Heinä 20251h

Prime Day's results, Beauty's wrestling opportunity — and a lawyer's take on beauty’s dupe lawsuits

Prime Day's results, Beauty's wrestling opportunity — and a lawyer's take on beauty’s dupe lawsuits

Beauty dupes have never been more popular. But is mimicking a competitor a sound business decision?   “This might surprise people, [but] dupes may not be illegal on their own," brand protection attor...

17 Heinä 202542min

Debut Biotech’s Joshua Britton on the breakthrough beetle pigment set to disrupt beauty, plus Amazon Prime sale news

Debut Biotech’s Joshua Britton on the breakthrough beetle pigment set to disrupt beauty, plus Amazon Prime sale news

The female cochineal beetle may not be aware of it, but it owes a debt of gratitude to Joshua Britton. In February, Britton’s Debut Biotech unveiled a breakthrough set to disrupt how beauty produc...

10 Heinä 202538min

Unilever's acquisition, Glossier's CEO shakeup and Arrae's Siff Haider on predicting wellness trends

Unilever's acquisition, Glossier's CEO shakeup and Arrae's Siff Haider on predicting wellness trends

In the big wide world of health and wellness, there is always a buzzword du jour. In the past couple months, you've likely heard buzz about gut health and GLP-1s, ingredients like creatine and colostr...

26 Kesä 202543min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
hyva-paha-johtaminen
rss-rahamania
ostan-asuntoja-podcast
herrasmieshakkerit
rss-tarkeista-asioista-2
rss-sami-miettinen-neuvottelija
rahapuhetta
rss-lahtijat
rss-rentotapaus
rss-sisalto-kuntoon
rss-seuraava-potilas
pomojen-suusta
sijoituspodi
rss-muutoksenanatomiaa-podcast
rss-uppoava-vn-laiva
rss-tyoelaman-timantteja